KalVista Pharmaceuticals (KALV) Accumulated Depreciation & Amortization (2017 - 2024)
KalVista Pharmaceuticals' Accumulated Depreciation & Amortization history spans 8 years, with the latest figure at $3.7 million for Q2 2024.
- For Q2 2024, Accumulated Depreciation & Amortization changed N/A year-over-year to $3.7 million; the TTM value through Apr 2024 reached $3.7 million, changed N/A, while the annual FY2024 figure was $3.7 million, N/A changed from the prior year.
- Accumulated Depreciation & Amortization for Q2 2024 was $3.7 million at KalVista Pharmaceuticals, up from $1.4 million in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $3.7 million in Q2 2024 and bottomed at $1.4 million in Q2 2020.